139 related articles for article (PubMed ID: 36920835)
1. Amitriptyline, Duloxetine, and Pregabalin Each Effective in Decreasing Pain From Diabetic Peripheral Neuropathy; Combinations Even Better.
Barry HC
Am Fam Physician; 2023 Mar; 107(3):316-317. PubMed ID: 36920835
[No Abstract] [Full Text] [Related]
2. Combination therapy for painful diabetic neuropathy is safe and effective.
Saul H; Deeney B; Imison C; Tesfaye S
BMJ; 2023 Apr; 381():866. PubMed ID: 37085164
[TBL] [Abstract][Full Text] [Related]
3. Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial.
Selvarajah D; Petrie J; White D; Julious S; Bortolami O; Cooper C; Bradburn M; Loban A; Bowler H; Swaby L; Sutherland K; Tesfaye S;
Trials; 2018 Oct; 19(1):578. PubMed ID: 30348206
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.
Carlos F; Espejel L; Novick D; López R; Flores D
Medwave; 2015 Sep; 15(8):e6265. PubMed ID: 26460688
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Pregabalin Compared to Duloxetine in Diabetic Peripheral Neuropathic Pain: An Observational Study.
Jha S; Sahani OP; Siddiqui S; Verma MK; Mazumder A; Waghdhare S
J Assoc Physicians India; 2019 Nov; 67(11):32-36. PubMed ID: 31793266
[TBL] [Abstract][Full Text] [Related]
6. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life.
Boyle J; Eriksson ME; Gribble L; Gouni R; Johnsen S; Coppini DV; Kerr D
Diabetes Care; 2012 Dec; 35(12):2451-8. PubMed ID: 22991449
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine in Painful Diabetic Neuropathy: A Systematic Review.
Hossain SM; Hussain SM; Ekram AR
Clin J Pain; 2016 Nov; 32(11):1005-1010. PubMed ID: 26710221
[TBL] [Abstract][Full Text] [Related]
8. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.
Bouhassira D; Wilhelm S; Schacht A; Perrot S; Kosek E; Cruccu G; Freynhagen R; Tesfaye S; Lledó A; Choy E; Marchettini P; Micó JA; Spaeth M; Skljarevski V; Tölle T
Pain; 2014 Oct; 155(10):2171-9. PubMed ID: 25168665
[TBL] [Abstract][Full Text] [Related]
9. A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine.
Ellis JJ; Sadosky AB; Ten Eyck LL; Mudumby P; Cappelleri JC; Ndehi L; Suehs BT; Parsons B
BMC Health Serv Res; 2015 Apr; 15():159. PubMed ID: 25889173
[TBL] [Abstract][Full Text] [Related]
10. Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
Marchettini P; Wilhelm S; Petto H; Tesfaye S; Tölle T; Bouhassira D; Freynhagen R; Cruccu G; Lledó A; Choy E; Kosek E; Micó JA; Späth M; Skljarevski V; Lenox-Smith A; Perrot S
Eur J Pain; 2016 Mar; 20(3):472-82. PubMed ID: 26311228
[TBL] [Abstract][Full Text] [Related]
11. Treating Painful Diabetic Peripheral Neuropathy: An Update.
Snyder MJ; Gibbs LM; Lindsay TJ
Am Fam Physician; 2016 Aug; 94(3):227-34. PubMed ID: 27479625
[TBL] [Abstract][Full Text] [Related]
12. Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.
van Nooten F; Treur M; Pantiri K; Stoker M; Charokopou M
Clin Ther; 2017 Apr; 39(4):787-803.e18. PubMed ID: 28365034
[TBL] [Abstract][Full Text] [Related]
13. Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine.
Bellows BK; Nelson RE; Oderda GM; LaFleur J
Pain; 2016 Jan; 157(1):203-213. PubMed ID: 26397932
[TBL] [Abstract][Full Text] [Related]
14. Diabetic Peripheral Neuropathy: Prevention and Treatment.
Bragg S; Marrison ST; Haley S
Am Fam Physician; 2024 Mar; 109(3):226-232. PubMed ID: 38574212
[TBL] [Abstract][Full Text] [Related]
15. Drug combinations in diabetic neuropathic pain: an experimental validation.
Tripathi CD; Mehta AK; Yadav AM
J Basic Clin Physiol Pharmacol; 2016 Nov; 27(6):617-624. PubMed ID: 27331307
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Treatment of Diabetic Peripheral Neuropathy: An Update.
Rafiullah M; Siddiqui K
CNS Neurol Disord Drug Targets; 2022; 21(10):884-900. PubMed ID: 33655879
[TBL] [Abstract][Full Text] [Related]
17. [Medical Treatment of Chronic Pain].
Nodera H
Brain Nerve; 2023 Mar; 75(3):227-234. PubMed ID: 36890758
[TBL] [Abstract][Full Text] [Related]
18. Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
Tesfaye S; Wilhelm S; Lledo A; Schacht A; Tölle T; Bouhassira D; Cruccu G; Skljarevski V; Freynhagen R
Pain; 2013 Dec; 154(12):2616-2625. PubMed ID: 23732189
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.
Stepanović-Petrović R; Micov A; Tomić M; Pecikoza U
Psychopharmacology (Berl); 2017 Jun; 234(11):1781-1794. PubMed ID: 28332005
[TBL] [Abstract][Full Text] [Related]
20. Pregabalin and amitriptyline as first-line drugs among patients with painful peripheraldiabetic neuropathy: a systematic review and meta-analysis.
Alhowiti AM; Mirghani HO
Eur Rev Med Pharmacol Sci; 2024 May; 28(10):3598-3606. PubMed ID: 38856135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
